EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Consensus Guideline DTECH: Technology for Glycemic Control in Type 1 Diabetes

Dhruvi Hasnani, Banshi Saboo, Sujoy Ghosh, Rakesh Parikh, Minal Mohit, Ghanshyam Das Ramchandani, Amit Gupta, Mithun Bhartia, Manoj Chawla, Rishi Shukla, Lotika Purohit, Hitesh Saraogi und 12 weitere

Journal of Diabetology · 2026-07 · 17 (4) · 379-387

DOI: 10.4103/jod.jod_36_26 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Diabetology, online erschienen am 28.07.2026. Verfasst von Dhruvi Hasnani und 23 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 1 diabetes (T1D) requires intensive insulin therapy and continuous glucose monitoring (CGM) to achieve optimal glycemic control. Advances in diabetes technology, including CGM, insulin pumps, and hybrid closed-loop (HCL) systems, have significantly improved clinical outcomes. However, their adoption in India remains variable due to cost, infrastructure, and access limitations.

Objective

To develop a consensus guideline on the use of diabetes technology for glycemic management in T1D, with a contextual relevance to the Indian healthcare setting. Materials and Methods: This guideline was developed through a structured, expert-driven process involving a panel of 25 specialists across India. A focused literature review (2010–2025) was conducted using PubMed/MEDLINE and Embase. Evidence was appraised and graded using a modified Grading of Recommendations Assessment, Development and Evaluation approach, and recommendations were formulated through iterative expert consensus.

Results

CGM improves glycemic control, reduces hypoglycemia, and enhances patient engagement. Insulin pump therapy offers greater dosing precision and flexibility, whereas HCL systems further optimize time in range and reduce glycemic variability. Mobile health and telemedicine provide additional benefits through remote monitoring and improved access to care. A stepwise approach to technology adoption—from optimized standard care to advanced automated systems—is recommended. Key barriers in India include affordability, limited trained personnel, and infrastructure constraints.

Conclusion

Diabetes technology represents a paradigm shift in the management of T1D, with the potential to consistently improve glycemic outcomes, reduce complications, and enhance quality of life across diverse patient populations. In the Indian context, the imperative now extends beyond adoption to equitable integration, ensuring that these technologies are accessible, affordable, and sustainably implemented across all levels of care. Achieving this will require coordinated efforts in structured education, capacity building, policy support, and innovative care models. Ultimately, diabetes technology must be regarded not as an optional adjunct, but as a standard of care, with the goal of delivering better outcomes for every individual living with T1D.

Zitieren

APA

Hasnani, D., Saboo, B., Ghosh, S., Parikh, R., Mohit, M., Ramchandani, G. D., Gupta, A., Bhartia, M., Chawla, M., Shukla, R., Purohit, L., Saraogi, H., Meher, M., Saxena, R., Sailor, V., Lodha, S., Mehta, A., Mohanty, S., Bhambhani, Y., …, & Kesavadev, J. (2026). Consensus Guideline DTECH: Technology for Glycemic Control in Type 1 Diabetes. Journal of Diabetology, 17(4), 379-387. https://doi.org/10.4103/jod.jod_36_26

Vancouver

Hasnani D, Saboo B, Ghosh S, Parikh R, Mohit M, Ramchandani GD, et al. Consensus Guideline DTECH: Technology for Glycemic Control in Type 1 Diabetes. Journal of Diabetology. 2026;17(4):379-387. doi:10.4103/jod.jod_36_26

BibTeX
@article{Hasnani2026,
  author = {Hasnani, Dhruvi and Saboo, Banshi and Ghosh, Sujoy and Parikh, Rakesh and Mohit, Minal and Ramchandani, Ghanshyam Das and Gupta, Amit and Bhartia, Mithun and Chawla, Manoj and Shukla, Rishi and Purohit, Lotika and Saraogi, Hitesh and Meher, Meghanad and Saxena, Rajnish and Sailor, Vikranti and Lodha, Sailesh and Mehta, Anushree and Mohanty, Soumyaranjan and Bhambhani, Yusuf and Agrawal, Manoj and Gandhi, Sanjay Popatlal and Sarda, Archana and Saiyed, Mahira and Kesavadev, Jothydev},
  title = {Consensus Guideline DTECH: Technology for Glycemic Control in Type 1 Diabetes},
  journal = {Journal of Diabetology},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {379--387},
  doi = {10.4103/jod.jod_36_26}
}
Kostenlos starten →